|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2018
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/11288
Title: | Contemporary diagnosis of oncoviruses |
Authors: | Zamisnii, Galina |
Keywords: | diagnosis;HPV;oncovirus;colposcopy;oncogene |
Issue Date: | 2018 |
Publisher: | MedEspera |
Citation: | ZAMISNII, Galina. Contemporary diagnosis of oncoviruses. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 196-197. |
Abstract: | Introduction. The topic of this paper is the contemporary diagnosis of the oncoviruses. The
general objective of our research is to develop and deepen the concept of oncoviruses. The key
concepts we have worked with are the following: malignant transformations, skin tumors, DNA
genome, Epstein-Barr virus, B or C hepatitis virus, human papilloma virus, cervical cancer,
Papanicola test and HPV test.
Aim of the study. Identification and analysis of infectious origin of oncoviruses, contemporary
diagnosis of oncoviruses, and especially HPV has been investigated. This review summarizes the
molecular testing methods currently used for the detection and genotyping of HPV DNA and
discusses future potential approaches.
Materials and methods. Investigational protocol included: General Blood Test and Biochemical
test, Antigen Antibody Test for Epstein-Barr Virus, Abdominal Ecography, CT with Contrast
Substances, MRI, Babes Papanicolau Test, HPV Test, Colposcopy, Cervical Biopsy.
Results. The results of the study indicate a modern approach with the inclusion of a new
research vision in the field of oncoviruses and the determination of a correct diagnosis.
Conclusions. Finally, in our opinion, much more information is needed on the prevalence of
globally high-risk oncogenic serotypes, information needed both to implement a screening
program that includes diagnostic tests for the most prevalent serotypes, as well as for the establishment of a vaccination program. Further research is also needed to generate data on longterm
clinical effectiveness and duration of protection, following 2 and 3-dose regimens. |
URI: | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf http://repository.usmf.md/handle/20.500.12710/11288 |
Appears in Collections: | MedEspera 2018
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|